BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29638)

  • 1. Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1445-54. PubMed ID: 29638
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.
    Bilezikian JP; Dornfeld AM; Gammon DE
    Biochem Pharmacol; 1978 May; 27(10):1455-61. PubMed ID: 29639
    [No Abstract]   [Full Text] [Related]  

  • 3. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.
    Weiland GA; Minneman KP; Molinoff PB
    Nature; 1979 Sep; 281(5727):114-7. PubMed ID: 38405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine and guanine nucleotide activation of skeletal muscle adenylate cyclase.
    Nambi P; Drummond GI
    Biochim Biophys Acta; 1979 Mar; 583(3):287-94. PubMed ID: 36171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of beta-adrenergic agonist binding by guanylnucleotides in avian erythrocytes.
    Simpson IA; Pfeuffer T
    FEBS Lett; 1980 Jun; 115(1):113-7. PubMed ID: 6248374
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic receptors and adenylate cyclase activity in rat reticulocytes and mature erythrocytes.
    Beckman BS; Hollenberg MD
    Biochem Pharmacol; 1979; 28(2):239-48. PubMed ID: 218589
    [No Abstract]   [Full Text] [Related]  

  • 7. Turn on and turn off reactions of beta-adrenergic-sensitive adenylate cyclase in control and desensitized C6 glioma cells.
    Homburger V; Lucas M; Bockaert J
    FEBS Lett; 1982 May; 141(2):245-50. PubMed ID: 6124458
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-adrenergic receptor-adenylate cyclase of denervated sarcolemmal membrane.
    Smith PB; Grefrath SP; Appel SH
    Exp Neurol; 1978 May; 59(3):361-71. PubMed ID: 206455
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of turkey erythrocyte adenylate cyclase by two receptors: adenosine and catecholamines.
    Sevilla N; Tolkovsky AM; Levitzki A
    FEBS Lett; 1977 Sep; 81(2):339-41. PubMed ID: 200475
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenylate cyclase activation by the beta-adrenergic receptors as a diffusion-controlled process.
    Hanski E; Rimon G; Levitzki A
    Biochemistry; 1979 Mar; 18(5):846-53. PubMed ID: 217426
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the influence of N-isopropyl and N-tert butyl substituents on the affinity of ligands for sinoatrial beta-adrenoceptors in rat atria and beta-adrenoceptors coupled to the adenylyl cyclase in kitten ventricle.
    Kaumann AJ; Morris TH; Birnbaumer L
    Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):1-8. PubMed ID: 39258
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and regulation of beta-adrenergic receptors.
    Lefkowitz RJ
    Adv Exp Med Biol; 1978; 96():137-60. PubMed ID: 24993
    [No Abstract]   [Full Text] [Related]  

  • 13. A high affinity agonist . beta-adrenergic receptor complex is an intermediate for catecholamine stimulation of adenylate cyclase in turkey and frog erythrocyte membranes.
    Stadel JM; DeLean A; Lefkowitz RJ
    J Biol Chem; 1980 Feb; 255(4):1436-41. PubMed ID: 6243637
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydroxybenzylpindolol--activation mechanism of adenylate cyclase and beta-adrenergic receptor].
    Yamamura H
    Nihon Rinsho; 1976; 34(3):534-9. PubMed ID: 6811
    [No Abstract]   [Full Text] [Related]  

  • 15. Reconstitution of catecholamine-sensitive adenylate cyclase activity: interactions of solubilized components with receptor-replete membranes.
    Ross EM; Gilman AG
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3715-9. PubMed ID: 198799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow GDP dissociation from the guanyl nucleotide site of turkey erythrocyte membranes is not the rate limiting step in the activation of adenylate cylase by beta-adrenergic receptors.
    Levitzki A
    FEBS Lett; 1980 Jun; 115(1):9-10. PubMed ID: 6248377
    [No Abstract]   [Full Text] [Related]  

  • 18. Agonist-induced increase in apparent beta-adrenergic receptor size.
    Limbird LE; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):228-32. PubMed ID: 24213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of beta-adrenergic receptor-coupled adenylate cyclase: implications of a redox mechanism for the action of agonists at beta-adrenergic receptors.
    Wong A; Hwang SM; Cheng HY; Crooke ST
    Mol Pharmacol; 1987 Apr; 31(4):368-76. PubMed ID: 2883567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the beta-adrenergic receptor and adenylate cyclase in skeletal muscle plasma membranes.
    Grefrath ST; Smith PB; Appel SH
    Arch Biochem Biophys; 1978 Jun; 188(2):328-37. PubMed ID: 209751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.